1. Home
  2. GSIT vs LCTX Comparison

GSIT vs LCTX Comparison

Compare GSIT & LCTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GSIT
  • LCTX
  • Stock Information
  • Founded
  • GSIT 1995
  • LCTX 1990
  • Country
  • GSIT United States
  • LCTX United States
  • Employees
  • GSIT N/A
  • LCTX N/A
  • Industry
  • GSIT Semiconductors
  • LCTX Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • GSIT Technology
  • LCTX Health Care
  • Exchange
  • GSIT Nasdaq
  • LCTX Nasdaq
  • Market Cap
  • GSIT 98.7M
  • LCTX 107.3M
  • IPO Year
  • GSIT N/A
  • LCTX N/A
  • Fundamental
  • Price
  • GSIT $3.19
  • LCTX $1.20
  • Analyst Decision
  • GSIT
  • LCTX Strong Buy
  • Analyst Count
  • GSIT 0
  • LCTX 5
  • Target Price
  • GSIT N/A
  • LCTX $4.20
  • AVG Volume (30 Days)
  • GSIT 334.9K
  • LCTX 1.7M
  • Earning Date
  • GSIT 07-31-2025
  • LCTX 08-12-2025
  • Dividend Yield
  • GSIT N/A
  • LCTX N/A
  • EPS Growth
  • GSIT N/A
  • LCTX N/A
  • EPS
  • GSIT N/A
  • LCTX N/A
  • Revenue
  • GSIT $22,130,000.00
  • LCTX $10,914,000.00
  • Revenue This Year
  • GSIT N/A
  • LCTX N/A
  • Revenue Next Year
  • GSIT N/A
  • LCTX $244.95
  • P/E Ratio
  • GSIT N/A
  • LCTX N/A
  • Revenue Growth
  • GSIT 6.14
  • LCTX 76.43
  • 52 Week Low
  • GSIT $1.62
  • LCTX $0.37
  • 52 Week High
  • GSIT $5.89
  • LCTX $1.31
  • Technical
  • Relative Strength Index (RSI)
  • GSIT 34.31
  • LCTX 67.31
  • Support Level
  • GSIT $3.05
  • LCTX $0.97
  • Resistance Level
  • GSIT $3.42
  • LCTX $1.09
  • Average True Range (ATR)
  • GSIT 0.25
  • LCTX 0.09
  • MACD
  • GSIT -0.13
  • LCTX 0.01
  • Stochastic Oscillator
  • GSIT 8.97
  • LCTX 69.44

About GSIT GSI Technology

GSI Technology Inc is a provider of semiconductor memory solutions. The company develops and markets high-performance memory products, including Very Fast static random access memory, or SRAM, that are incorporated in high-performance networking and telecommunications equipment, such as routers, switches, wide area network infrastructure equipment, wireless base stations, and network access equipment. It sells these products to original equipment manufacturers and customers including Nokia. In addition, it serves the ongoing needs of the military, aerospace, industrial, test and measurement equipment, and automotive and medical markets for high-performance SRAMs. It operates geographically in China, Singapore, the Netherlands, Germany, Rest of the world, and the United States.

About LCTX Lineage Cell Therapeutics Inc.

Lineage Cell Therapeutics Inc is a clinical-stage biotechnology company focused on the development and commercialization of novel therapies for the treatment of degenerative diseases. The company's pipeline is based on two platform technologies including cell replacement and cell/drug delivery. Lineage Cell's product candidate is OpRegen, a retinal pigment epithelium transplant therapy for the treatment of dry age-related macular degeneration, OPC1, an oligodendrocyte progenitor cell therapy for acute spinal cord injuries, and VAC2, allogeneic cancer immunotherapy of antigen-presenting dendritic cells for non-small cell lung cancer, ANP1, an allogeneic auditory neuron progenitor cells transplant for hearing loss, and PNC1, an allogeneic photoreceptor cell transplant for vision loss.

Share on Social Networks: